東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Innovative leukemia and lymphoma therapy

Kaspers, G. J. L., (1963-)

Linked to FindBook

Google Book

Amazon

博客來

Innovative leukemia and lymphoma therapy

Record Type:	Electronic resources : Monograph/item
Title/Author:	Innovative leukemia and lymphoma therapy/ edited by Gertjan J.L. Kaspers ... [et al.].
other author:	Kaspers, G. J. L.,
Published:	New York :Informa Healthcare, : c2008.,
Description:	xiv, 598 p. :ill.
[NT 15003449]:	1. Gene expression profiling to detect new treatment targets in leukemia and lymphoma : a future perspective / Torsten Haferlach, Wolfgang Kern, and Alexander Kohlmann -- 2. Individualized tumor response testing in leukemia and lymphoma / Andrew G. Bosanquet, Peter Nygren, and Larry M. Weisenthal -- 3. Minimal residual disease / Jacques J. M. van Dongen, Tomasz Szczep�anski, and Vincent H. J. van der Velden -- 4. New methods for clinical trials : AML as an example / Elihu Estey -- 5. Monoclonal antibody mediated treatment in acute myeloid leukemia / Ch. Michel Zwaan and Marry M. van den Heuvel-Eibrink -- 6. Monoclonal antibodies in the treatment of malignant lymphomas and chronic lymphocytic leukemia / Bertrand Coiffier -- 7. Radioimmunotherapy of hematological malignancies / Tim Illidge and James Hainsworth -- 8. Differentiation induction in acute promyelocytic leukemia / Adi Gidron and Martin S. Tallman -- 9. DNA methylation and epigenetics : new developments in biology and treatment / Jesus Duque, Michael L�ubbert, and Mark Kirschbaum -- 10. The emerging role of histone deacetylase inhibitors in the treatment of lymphoma / Matko Kalac and Owen A. O'Connor -- 11. Antileukemic treatment targeted at apoptosis regulators / Simone Fulda and Klaus-Michael Debatin -- 12. Angiogenesis in hematological malignancies / Alida C. Weidenaar, Hendrik J. M. de Jonge, Arja ter Elst, and Evelina S. J. M. de Bont -- 13. Nucleic acid-based, mRNA-targeted therapeutics for hematologic malignancies / Alan M. Gewirtz -- 14. Active specific immunization by the use of leukemic dendritic cell vaccines / Ilse Houtenbos, Gert J. Ossenkoppele, and Arjan A. van de Loosdrecht -- 15. CDK inhibitors in leukemia and lymphoma / Yun Dai and Steven Grant -- 16. FLT3 : a receptor tyrosine kinase target in adult and pediatric AML / Mark Levis, Patrick Brown, and Donald Small -- 17. Treatment of chronic myeloid leukemia with Bcr-Abl kinase inhibitors / Michael J. Mauro and Michael C. Heinrich -- 18. Tyrosine kinase inhibitors : targets other than FLT3, BCR-ABL, and c-KIT / Suzanne R. Hayman and Judith E. Karp -- 19. Tyrosine phosphatases as new treatment targets in acute myeloid leukemia / I. Hubeek ... [et al.] -- 20. Proteasome and protease inhibitors / N. E. Franke ... [et al.] -- 21. Farnesyltransferase inhibitors : current and prospective development for hematologic malignancies / Judith E. Karp -- 22. Targeting notch pathways / Jennifer O'Neil and A. Thomas Look -- 23. mTOR targeting agents for the treatment of lymphoma and leukemia / Andrea E. Wahner Hendrickson, Thomas E. Witzig, and Scott H. Kaufmann -- 24. Allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning / Fr�ed�eric Baron, Frederick R. Appelbaum, and Brenda M. Sandmaier -- 25. Modulation of classical multidrug resistance and drug resistance in general / Branimir I. Sikic.
Subject:	Leukemia - Treatment. -
Online resource:	http://marc.crcnetbase.com/isbn/9781420014082Distributed by publisher. Purchase or institutional license may be required for access.
ISBN:	9781420014082 (ebook : PDF)

Innovative leukemia and lymphoma therapy
Innovative leukemia and lymphoma therapy[electronic resource] /edited by Gertjan J.L. Kaspers ... [et al.]. - New York :Informa Healthcare,c2008. - xiv, 598 p. :ill. - Basic and clinical oncology ;35. - Basic and clinical oncology ;35.

Includes bibliographical references and index.

1. Gene expression profiling to detect new treatment targets in leukemia and lymphoma : a future perspective / Torsten Haferlach, Wolfgang Kern, and Alexander Kohlmann -- 2. Individualized tumor response testing in leukemia and lymphoma / Andrew G. Bosanquet, Peter Nygren, and Larry M. Weisenthal -- 3. Minimal residual disease / Jacques J. M. van Dongen, Tomasz Szczep�anski, and Vincent H. J. van der Velden -- 4. New methods for clinical trials : AML as an example / Elihu Estey -- 5. Monoclonal antibody mediated treatment in acute myeloid leukemia / Ch. Michel Zwaan and Marry M. van den Heuvel-Eibrink -- 6. Monoclonal antibodies in the treatment of malignant lymphomas and chronic lymphocytic leukemia / Bertrand Coiffier -- 7. Radioimmunotherapy of hematological malignancies / Tim Illidge and James Hainsworth -- 8. Differentiation induction in acute promyelocytic leukemia / Adi Gidron and Martin S. Tallman -- 9. DNA methylation and epigenetics : new developments in biology and treatment / Jesus Duque, Michael L�ubbert, and Mark Kirschbaum -- 10. The emerging role of histone deacetylase inhibitors in the treatment of lymphoma / Matko Kalac and Owen A. O'Connor -- 11. Antileukemic treatment targeted at apoptosis regulators / Simone Fulda and Klaus-Michael Debatin -- 12. Angiogenesis in hematological malignancies / Alida C. Weidenaar, Hendrik J. M. de Jonge, Arja ter Elst, and Evelina S. J. M. de Bont -- 13. Nucleic acid-based, mRNA-targeted therapeutics for hematologic malignancies / Alan M. Gewirtz -- 14. Active specific immunization by the use of leukemic dendritic cell vaccines / Ilse Houtenbos, Gert J. Ossenkoppele, and Arjan A. van de Loosdrecht -- 15. CDK inhibitors in leukemia and lymphoma / Yun Dai and Steven Grant -- 16. FLT3 : a receptor tyrosine kinase target in adult and pediatric AML / Mark Levis, Patrick Brown, and Donald Small -- 17. Treatment of chronic myeloid leukemia with Bcr-Abl kinase inhibitors / Michael J. Mauro and Michael C. Heinrich -- 18. Tyrosine kinase inhibitors : targets other than FLT3, BCR-ABL, and c-KIT / Suzanne R. Hayman and Judith E. Karp -- 19. Tyrosine phosphatases as new treatment targets in acute myeloid leukemia / I. Hubeek ... [et al.] -- 20. Proteasome and protease inhibitors / N. E. Franke ... [et al.] -- 21. Farnesyltransferase inhibitors : current and prospective development for hematologic malignancies / Judith E. Karp -- 22. Targeting notch pathways / Jennifer O'Neil and A. Thomas Look -- 23. mTOR targeting agents for the treatment of lymphoma and leukemia / Andrea E. Wahner Hendrickson, Thomas E. Witzig, and Scott H. Kaufmann -- 24. Allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning / Fr�ed�eric Baron, Frederick R. Appelbaum, and Brenda M. Sandmaier -- 25. Modulation of classical multidrug resistance and drug resistance in general / Branimir I. Sikic.

Mode of access: World Wide Web.

ISBN: 9781420014082 (ebook : PDF)Subjects--Topical Terms:

1359573
Leukemia
--Treatment.Index Terms--Genre/Form:

542853
Electronic books.

Innovative leukemia and lymphoma therapy
LDR:03925cmm 2200265Ia 4500 001 1988188
003 FlBoTFG
005 20131227135217.0
006 m|||||o||d||||||||
007 cr||||
008 150804s2008 nyua ob 001 0 eng d
020 $a 9781420014082 (ebook : PDF)
035 $a CRC0DKE0832PDF
040 $a FlBoTFG $c FlBoTFG
090 $a RC643 $b .I46 2008
092 $a 616.9941906 $b I586
245 0 0 $a Innovative leukemia and lymphoma therapy $h [electronic resource] / $c edited by Gertjan J.L. Kaspers ... [et al.].
260 $a New York : $b Informa Healthcare, $c c2008.
300 $a xiv, 598 p. : $b ill.
490 1 $a Basic and clinical oncology ; $v 35
504 $a Includes bibliographical references and index.
505 0 $a 1. Gene expression profiling to detect new treatment targets in leukemia and lymphoma : a future perspective / Torsten Haferlach, Wolfgang Kern, and Alexander Kohlmann -- 2. Individualized tumor response testing in leukemia and lymphoma / Andrew G. Bosanquet, Peter Nygren, and Larry M. Weisenthal -- 3. Minimal residual disease / Jacques J. M. van Dongen, Tomasz Szczep�anski, and Vincent H. J. van der Velden -- 4. New methods for clinical trials : AML as an example / Elihu Estey -- 5. Monoclonal antibody mediated treatment in acute myeloid leukemia / Ch. Michel Zwaan and Marry M. van den Heuvel-Eibrink -- 6. Monoclonal antibodies in the treatment of malignant lymphomas and chronic lymphocytic leukemia / Bertrand Coiffier -- 7. Radioimmunotherapy of hematological malignancies / Tim Illidge and James Hainsworth -- 8. Differentiation induction in acute promyelocytic leukemia / Adi Gidron and Martin S. Tallman -- 9. DNA methylation and epigenetics : new developments in biology and treatment / Jesus Duque, Michael L�ubbert, and Mark Kirschbaum -- 10. The emerging role of histone deacetylase inhibitors in the treatment of lymphoma / Matko Kalac and Owen A. O'Connor -- 11. Antileukemic treatment targeted at apoptosis regulators / Simone Fulda and Klaus-Michael Debatin -- 12. Angiogenesis in hematological malignancies / Alida C. Weidenaar, Hendrik J. M. de Jonge, Arja ter Elst, and Evelina S. J. M. de Bont -- 13. Nucleic acid-based, mRNA-targeted therapeutics for hematologic malignancies / Alan M. Gewirtz -- 14. Active specific immunization by the use of leukemic dendritic cell vaccines / Ilse Houtenbos, Gert J. Ossenkoppele, and Arjan A. van de Loosdrecht -- 15. CDK inhibitors in leukemia and lymphoma / Yun Dai and Steven Grant -- 16. FLT3 : a receptor tyrosine kinase target in adult and pediatric AML / Mark Levis, Patrick Brown, and Donald Small -- 17. Treatment of chronic myeloid leukemia with Bcr-Abl kinase inhibitors / Michael J. Mauro and Michael C. Heinrich -- 18. Tyrosine kinase inhibitors : targets other than FLT3, BCR-ABL, and c-KIT / Suzanne R. Hayman and Judith E. Karp -- 19. Tyrosine phosphatases as new treatment targets in acute myeloid leukemia / I. Hubeek ... [et al.] -- 20. Proteasome and protease inhibitors / N. E. Franke ... [et al.] -- 21. Farnesyltransferase inhibitors : current and prospective development for hematologic malignancies / Judith E. Karp -- 22. Targeting notch pathways / Jennifer O'Neil and A. Thomas Look -- 23. mTOR targeting agents for the treatment of lymphoma and leukemia / Andrea E. Wahner Hendrickson, Thomas E. Witzig, and Scott H. Kaufmann -- 24. Allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning / Fr�ed�eric Baron, Frederick R. Appelbaum, and Brenda M. Sandmaier -- 25. Modulation of classical multidrug resistance and drug resistance in general / Branimir I. Sikic.
530 $a Also available in print format.
538 $a Mode of access: World Wide Web.
650 0 $a Leukemia $x Treatment. $3 1359573
650 0 $a Lymphomas $x Treatment. $3 1359574
655 7 $a Electronic books. $2 lcsh $3 542853
700 1 $a Kaspers, G. J. L., $d 1963- $3 2123163
776 0 8 $z 9780849350832 (hardcover : alk. paper) $z 0849350832 (hardcover : alk. paper)
830 0 $a Basic and clinical oncology ; $v 35 $3 1359572
856 4 0 $u http://marc.crcnetbase.com/isbn/9781420014082 $q application/PDF $z Distributed by publisher. Purchase or institutional license may be required for access.